DKK3 protein found to protect against atherosclerosisDescribed 11 July 2017 in Circulation, a study led by an international research team has shown that a cytokine-like protein DKK3 provides protection against atherosclerosis. Accordingly, the protein DKK3 is considered a ... Detailed information
New insights into the mechanism underlying lupusA study, led by Betty Diamond at the Feinstein Institute for Medical Research, has uncovered a mechanism underlying lupus, a systemic autoimmune disease characterized by abnormal immune responses leading to autoantibody ... Detailed information
Research offers a new way for developing TB drugsMycobacterium tuberculosis (Mtb) is the bacterium that causes the serious disease tuberculosis (TB). This pathogen infects about 1.5 billion individuals around the world and carries away 1 million of lives annually. The ... Detailed information
Anti-CFH antibody promotes the effects of a CLL drugRituximab, a chimeric monoclonal antibody against the protein CD20, is a drug used to treat a range of autoimmune diseases and cancers, such as chronic B cell lymphocytic leukemia (B-CLL). But patients with B-CLL respond... Detailed information
New findings of a study may help combat heart diseaseA study appearing in eLife identifies a new mechanism that regulates heart hypertrophy, a finding that may lead to new drugs for treating heart disease.
Cellular growth and function is largely dependent on protein syn... Detailed information
Inhibitors of AniA might be used to treat gonorrheaGonorrhea is a common bacterial sexually transmitted infection, with an estimated 78 million new cases occurring annually worldwide. It is caused by the bacteria Neisseria gonorrhoeae, which mainly affects reproductive a... Detailed information
Scientists find a way to reduce organ rejectionScientists from the University of Pittsburgh School of Medicine in the USA, Hospital for Sick Children Research Institute in Canada, and Kobe University Graduate School of Medicine in Japan have identified a molecular me... Detailed information
New solution for combating cancerA team of researchers has recently identified a new way to combating cancer. The study, reported in Nature Chemical Biology on 5 June 2017, has shown that blocking DCN1 from binding to UB2EM could suppress cancer growth.... Detailed information
Study sheds light on the working mechanism of ketamineResearchers at the University of Texas Southwestern Medical Center (UT Southwestern) have identified a mechanism by which ketamine exerts its antidepressant effects and causes unwanted side effects. This discovery may he... Detailed information
RBM12 is involved in psychosis, study findsA collaborative team consisting of scientists from Iceland, Finland, and Germany has identified a novel genetic mutation that contributes to psychosis, an abnormal condition of the mind that involves the inability to rec... Detailed information
CARD11 mutations found to cause eczemaA study, led by researchers at National Institutes of Health (NIH) in the USA, has shown that genetic mutations in the CARD11 gene can trigger cellular defects associated with eczema.
Eczema, also known as dermatitis,... Detailed information
Research sheds light on regulation of JAK2Janus kinase 2, abbreviated JAK2, is a non-receptor kinase and is part of the JAK-STAT signaling pathway, which regulates immunity, proliferation, differentiation, apoptosis and oncogenesis. JAK2 is especially important ... Detailed information
New approach to combating Candida albicans infectionDescribed in the journal Nature Communications, a study reports a new way to combat fungal infections. The finding is significant because severe fungal infections afflict approximately 2 million people in the world annua... Detailed information
Lack of Pyk2 leads to cognitive impairments in miceA team led by investigators from Sorbonne Universités in France and Universitat de Barcelona in Spain has shown that a protein called Pyk2 is involved in spine structure and synaptic function, and that abnormalities in ... Detailed information
Malaria drug attenuates ALS progressionDescribed online in the Annals of Neurology, a study shows that a malaria drug called pyrimethamine is effective in reducing the levels of disease-causing proteins in amyotrophic lateral sclerosis (ALS).
The study is ... Detailed information